What's Happening?
A recent survey conducted by the Deloitte Center for Health Solutions reveals a significant shift in the diagnostics industry towards a business-to-business-to-consumer (B2B2C) operational model. The report indicates that 62% of diagnostics manufacturer
executives believe future growth depends on adopting this model. The study highlights a strategic disconnect between manufacturers and healthcare providers, with providers identifying test ordering as a major clinical friction point, while manufacturers focus on results interpretation. The rise of consumer-driven testing demands is reshaping the market, with 76% of providers stating that these demands will fundamentally alter diagnostics over the next three years. Interoperability remains a challenge, as 74% of healthcare providers report disconnected database systems across the diagnostic journey. To adapt, manufacturers must integrate AI within electronic health record (EHR) workflows and automate processes to deliver personalized data directly to consumers.
Why It's Important?
The shift towards a B2B2C model in the diagnostics industry is crucial as it reflects the growing consumerization of healthcare. This transition is driven by patients increasingly using digital health tools and wearables to manage their health independently. For manufacturers, this means moving beyond traditional product offerings to become workflow partners with healthcare providers. The integration of AI and interoperability is essential to meet consumer expectations for personalized and actionable health data. Failure to adapt could result in manufacturers losing market share to more agile, consumer-focused tech companies. This evolution also impacts healthcare providers, who must streamline operations to remain competitive in a consumer-driven marketplace.
What's Next?
Manufacturers are expected to re-engineer their interactions with healthcare providers to capture the emerging B2B2C opportunity. This involves addressing critical disconnects in problem-solving, stakeholder engagement, and consumer personalization. Providers are prioritizing peer-to-peer clinical education and digital self-service portals, while manufacturers need to shift focus from procurement relationships to clinical stakeholders. The urgency to fix these gaps is accelerating, with 76% of providers anticipating radical changes in diagnostics due to consumer-initiated testing demands. Manufacturers must prioritize comprehensive data and workflow integration to support providers in scaling personalized care.
Beyond the Headlines
The deeper implications of this shift include ethical and cultural dimensions, as the decentralization of testing into homes and retail environments changes the traditional patient-provider relationship. Consumers now expect clear, visual results that outline actionable next steps, challenging providers to deliver personalized care. This transformation also raises questions about data privacy and security, as more health data is generated and shared across platforms. The integration of AI and interoperable systems could lead to long-term shifts in how healthcare is delivered and experienced, potentially improving outcomes and patient satisfaction.
